(Q40978920)

English

A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer

scientific article published on 4 May 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

multicenter clinical trial

0 references

Jeremy A. Squire

19

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

object named as

Wei Wei

3

0 references

Lawrence D True

17

object named as

Lawrence D True

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

15

object named as

Peter S Nelson

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

author name string

Dean A Troyer

1

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Tamara Jamaspishvili

2

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Ziding Feng

4

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jennifer Good

5

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Sarah Hawley

6

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Ladan Fazli

7

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jesse K McKenney

8

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jeff Simko

9

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Antonio Hurtado-Coll

10

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Peter R Carroll

11

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Martin Gleave

12

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Raymond Lance

13

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Daniel W Lin

14

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Ian M Thompson

16

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

James D Brooks

18

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

publication date

4 May 2015

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

75

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

11

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

1206-1215

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, Internationa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Downgrading of biopsy based Gleason score in prostatectomy specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Overdiagnosis and overtreatment in cancer: an opportunity for improvement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Systematic, evidence-based discovery of biomarkers at the NCI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Active surveillance for prostate cancer: a systematic review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

The functions and regulation of the PTEN tumour suppressor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Implications of the International Society of Urological Pathology modified Gleason grading system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Prostate-cancer mortality at 11 years of follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Predicting 15-year prostate cancer specific mortality after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Cancer screening: the clash of science and intuition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

TMPRSS2-ETS fusion prostate cancer: biological and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

25 September 2017

Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

15 June 2018

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

15 June 2018

Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

15 June 2018

PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

19 August 2018

PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

19 August 2018

PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

19 August 2018

Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

19 August 2018

Clinical versus pathologic staging for prostate adenocarcinoma: how do they correlate?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

19 August 2018

PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

19 August 2018

Active surveillance for low-risk prostate cancer

2 references

https://api.crossref.org/works/10.1002%2FPROS.23003

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

4 November 2018

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

2 references

https://api.crossref.org/works/10.1002%2FPROS.23003

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

4 November 2018

Frequent inactivation of PTEN/MMAC1 in primary prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4475421

4 November 2018

Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23003

21 January 2018

PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23003

21 January 2018

Will Biomarkers Save Prostate Cancer Screening?

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23003

21 January 2018

The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25939393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in

1 reference

https://pubmed.ncbi.nlm.nih.gov/25939393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25939393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PROS.23003

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40978920&oldid=2191541959"